Aurobindo Pharma sets April 12 as record date for ₹800 crore buyback

Story Summary
The total buyback size represents 3.93 per cent and 2.62 per cent of the company’s paid-up equity share capital and free reserves, based on its latest standalone and consolidated financials, respectively | Photo: Company websiteBS Reporter Hyderabad-based Aurobindo Pharma on Monday fixed April 12, 2026, as the record date for its ₹800-crore.




